Medicines and vaccines have transformed the way we prevent, treat, and cure diseases. Bringing these to people around the world requires more than scientific breakthroughs \u2013 it demands collaboration across the entire innovation and access pathway. From discovery and development to regulatory approval, supply, procurement and local delivery, each step plays a critical role in ensuring people can benefit from medical innovation.<\/p>\n
New research carried out independently by the IQVIA Institute for Human Data Science, with funding from IFPMA, seeks to evaluate select pathways for two types of medicines in 18 low- and middle-income countries. The first, \u201crecently launched medicines\u201d, focuses on medicines first launched globally between 2013 and 2022. The second, \u201cestablished medicines\u201d, focuses on a selection of medicines from the 2023 version of the WHO Essential Medicines List (EML) excluding – among others – the \u201crecently launched\u201d entries.<\/p>\n
The analysis examines several factors that influence drug availability and accessibility: whether these medicines are registered locally, included on national essential medicines lists, reimbursed by healthcare systems, or sold in-country. These findings aim to provide key data to support discussions around these bottlenecks and inform strategies to improve access to essential and recently launched medicines.<\/p>\n
<\/p>\n","protected":false},"excerpt":{"rendered":"
Medicines and vaccines have transformed the way we prevent, treat, and cure diseases. Bringing these to people around the world requires more than scientific breakthroughs \u2013 it demands collaboration across the entire innovation and access pathway. From discovery and development to regulatory approval, supply, procurement and local delivery, each step plays a critical role in…<\/p>\n","protected":false},"featured_media":17579,"template":"","publication_type":[8],"topic":[67,15,62],"class_list":["post-17576","publications","type-publications","status-publish","has-post-thumbnail","hentry","publication_type-external-study","topic-access-to-medicines","topic-non-communicable-diseases","topic-universal-health-coverage"],"acf":[],"yoast_head":"\n